Matches in Wikidata for { <http://www.wikidata.org/entity/Q40406835> ?p ?o ?g. }
- Q40406835 description "2005 nî lūn-bûn" @default.
- Q40406835 description "2005 թվականի հուլիսի 8-ին հրատարակված գիտական հոդված" @default.
- Q40406835 description "2005年の論文" @default.
- Q40406835 description "2005年論文" @default.
- Q40406835 description "2005年論文" @default.
- Q40406835 description "2005年論文" @default.
- Q40406835 description "2005年論文" @default.
- Q40406835 description "2005年論文" @default.
- Q40406835 description "2005年论文" @default.
- Q40406835 description "2005年论文" @default.
- Q40406835 description "2005年论文" @default.
- Q40406835 description "2005年论文" @default.
- Q40406835 description "2005年论文" @default.
- Q40406835 description "2005年论文" @default.
- Q40406835 description "2005년 논문" @default.
- Q40406835 description "article científic" @default.
- Q40406835 description "article scientific" @default.
- Q40406835 description "article scientifique" @default.
- Q40406835 description "articol științific" @default.
- Q40406835 description "articolo scientifico" @default.
- Q40406835 description "artigo científico" @default.
- Q40406835 description "artigo científico" @default.
- Q40406835 description "artigo científico" @default.
- Q40406835 description "artikel ilmiah" @default.
- Q40406835 description "artikull shkencor" @default.
- Q40406835 description "artikulong pang-agham" @default.
- Q40406835 description "artykuł naukowy" @default.
- Q40406835 description "artículo científico publicado en 2005" @default.
- Q40406835 description "artículu científicu espublizáu en 2005" @default.
- Q40406835 description "bilimsel makale" @default.
- Q40406835 description "bài báo khoa học" @default.
- Q40406835 description "naučni članak" @default.
- Q40406835 description "scienca artikolo" @default.
- Q40406835 description "scientific article published on 8 July 2005" @default.
- Q40406835 description "scientific article published on 8 July 2005" @default.
- Q40406835 description "scientific article published on 8 July 2005" @default.
- Q40406835 description "teaduslik artikkel" @default.
- Q40406835 description "tieteellinen artikkeli" @default.
- Q40406835 description "tudományos cikk" @default.
- Q40406835 description "vedecký článok" @default.
- Q40406835 description "vetenskaplig artikel" @default.
- Q40406835 description "videnskabelig artikel" @default.
- Q40406835 description "vitenskapelig artikkel" @default.
- Q40406835 description "vitskapeleg artikkel" @default.
- Q40406835 description "vědecký článek" @default.
- Q40406835 description "wetenschappelijk artikel" @default.
- Q40406835 description "wissenschaftlicher Artikel" @default.
- Q40406835 description "επιστημονικό άρθρο" @default.
- Q40406835 description "мақолаи илмӣ" @default.
- Q40406835 description "наукова стаття, опублікована в липні 2005" @default.
- Q40406835 description "научна статия" @default.
- Q40406835 description "научная статья" @default.
- Q40406835 description "научни чланак" @default.
- Q40406835 description "научни чланак" @default.
- Q40406835 description "מאמר מדעי" @default.
- Q40406835 description "مقالة علمية نشرت في 8 يوليو 2005" @default.
- Q40406835 description "৮ জুলাই ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q40406835 description "บทความทางวิทยาศาสตร์" @default.
- Q40406835 description "სამეცნიერო სტატია" @default.
- Q40406835 name "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors." @default.
- Q40406835 name "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors." @default.
- Q40406835 type Item @default.
- Q40406835 label "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors." @default.
- Q40406835 label "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors." @default.
- Q40406835 prefLabel "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors." @default.
- Q40406835 prefLabel "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors." @default.
- Q40406835 P1433 Q40406835-F9433F2A-E498-48BB-9FA3-7106EEF68D50 @default.
- Q40406835 P1476 Q40406835-66D31CAA-294A-4A23-9CE5-895DF29CB807 @default.
- Q40406835 P2093 Q40406835-09DBEF05-3C39-4F6D-A3F6-A7FC5EA0519C @default.
- Q40406835 P2093 Q40406835-1041A247-5E4D-4CDF-91F2-4D4104440648 @default.
- Q40406835 P2093 Q40406835-5CFDC861-1508-4EBD-B1DB-53D130D7976E @default.
- Q40406835 P2093 Q40406835-5D7A577C-05F1-4CED-BA6B-7BC76F66D3AC @default.
- Q40406835 P2093 Q40406835-878CDD02-8C70-419D-A60D-98FF66FE37A2 @default.
- Q40406835 P2093 Q40406835-8C5E8A55-4B49-46E0-B736-81BDAC44DF20 @default.
- Q40406835 P2093 Q40406835-98CE952A-4910-4A22-8F41-E48A792ED04B @default.
- Q40406835 P2093 Q40406835-E3B96931-308A-40A7-AA8E-C6A0C6885A9F @default.
- Q40406835 P2860 Q40406835-5AE3BE26-E970-4303-8A7A-E1E7F0B8E7CC @default.
- Q40406835 P304 Q40406835-51966838-FE98-4D2C-A9BC-FD2981B1FD9B @default.
- Q40406835 P31 Q40406835-04CB2D1D-A935-4409-9240-3D359CBB72B8 @default.
- Q40406835 P356 Q40406835-3380BD49-4049-4803-86A5-FEEAB88FA6A5 @default.
- Q40406835 P433 Q40406835-4F74E77C-846D-47A3-8C20-59F5977F947A @default.
- Q40406835 P478 Q40406835-6B0FCC6C-8920-49D6-AEA7-24FCD5F90561 @default.
- Q40406835 P50 Q40406835-0371DDF8-F0D2-4E2F-A6D8-6B1EA440E41C @default.
- Q40406835 P577 Q40406835-1F3FFF71-24C8-4344-A8AB-628E317542B0 @default.
- Q40406835 P5875 Q40406835-87244C6F-032B-47BE-80AE-13A0F9A50019 @default.
- Q40406835 P698 Q40406835-A6AB698E-19E3-4DAE-BE6B-911C1FC2E0AF @default.
- Q40406835 P921 Q40406835-101D17E0-7364-461B-975C-1C8B29AD4E65 @default.
- Q40406835 P921 Q40406835-49398F27-8B4F-4F40-A168-26810D1E06BB @default.
- Q40406835 P356 MDI310 @default.
- Q40406835 P698 16006586 @default.
- Q40406835 P1433 Q326122 @default.
- Q40406835 P1476 "Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors" @default.
- Q40406835 P2093 "A Oza" @default.
- Q40406835 P2093 "C Lathia" @default.
- Q40406835 P2093 "F Cihon" @default.
- Q40406835 P2093 "H W Hirte" @default.
- Q40406835 P2093 "L Siu" @default.
- Q40406835 P2093 "M Moore" @default.
- Q40406835 P2093 "O Petrenciuc" @default.
- Q40406835 P2093 "S J Hotte" @default.